Sio Capital Management, LLC Eagle Pharmaceuticals, Inc. Transaction History

Sio Capital Management, LLC

  • $189 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2019

Aug 14, 2019
SELL
$46.61 - $58.45 $3.95 Million - $4.95 Million
-84,695 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$38.66 - $51.82 $3.27 Million - $4.39 Million
84,695 New
84,695 $4.28 Million
Q4 2017

Feb 14, 2018
SELL
$49.6 - $60.87 $3.17 Million - $3.89 Million
-63,835 Closed
0 $0
Q3 2017

Nov 14, 2017
BUY
$46.62 - $60.36 $2.98 Million - $3.85 Million
63,835
63,835 $3.81 Million

Others Institutions Holding EGRX

# of Institutions
70
Shares Held
8.6M
Call Options Held
1M
Put Options Held
100
View Full List

About EAGLE PHARMACEUTICALS, INC.

EGRX Quotes by TradingView
  • Ticker EGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 13,015,900
  • Market Cap $7.81M
  • Description
  • Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...
More about EGRX
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email